71 related articles for article (PubMed ID: 36736884)
1. Anti-CRISPR Protein AcrIIC5 Inhibits CRISPR-Cas9 by Occupying the Target DNA Binding Pocket.
Hwang S; Shah M; Garcia B; Hashem N; Davidson AR; Moraes TF; Maxwell KL
J Mol Biol; 2023 Apr; 435(7):167991. PubMed ID: 36736884
[TBL] [Abstract][Full Text] [Related]
2. Anti-CRISPR AcrIIC5 is a dsDNA mimic that inhibits type II-C Cas9 effectors by blocking PAM recognition.
Sun W; Zhao X; Wang J; Yang X; Cheng Z; Liu S; Wang J; Sheng G; Wang Y
Nucleic Acids Res; 2023 Feb; 51(4):1984-1995. PubMed ID: 36744495
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of CRISPR-SpyCas9 inhibition by an anti-CRISPR protein.
Dong D; Guo M; Wang S; Zhu Y; Wang S; Xiong Z; Yang J; Xu Z; Huang Z
Nature; 2017 Jun; 546(7658):436-439. PubMed ID: 28448066
[TBL] [Abstract][Full Text] [Related]
4. Structures of Neisseria meningitidis Cas9 Complexes in Catalytically Poised and Anti-CRISPR-Inhibited States.
Sun W; Yang J; Cheng Z; Amrani N; Liu C; Wang K; Ibraheim R; Edraki A; Huang X; Wang M; Wang J; Liu L; Sheng G; Yang Y; Lou J; Sontheimer EJ; Wang Y
Mol Cell; 2019 Dec; 76(6):938-952.e5. PubMed ID: 31668930
[TBL] [Abstract][Full Text] [Related]
5. Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins.
Lee J; Mir A; Edraki A; Garcia B; Amrani N; Lou HE; Gainetdinov I; Pawluk A; Ibraheim R; Gao XD; Liu P; Davidson AR; Maxwell KL; Sontheimer EJ
mBio; 2018 Dec; 9(6):. PubMed ID: 30514786
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the anti-CRISPR, AcrIIC4.
Kim GE; Lee SY; Park HH
Protein Sci; 2021 Dec; 30(12):2474-2481. PubMed ID: 34676610
[TBL] [Abstract][Full Text] [Related]
7. Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type IIC Anti-CRISPR Proteins.
Zhu Y; Gao A; Zhan Q; Wang Y; Feng H; Liu S; Gao G; Serganov A; Gao P
Mol Cell; 2019 Apr; 74(2):296-309.e7. PubMed ID: 30850331
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of inhibition of CRISPR-Cas9 by anti-CRISPR protein AcrIIC1.
Zhu Y; Yin S; Li Z
Biochem Biophys Res Commun; 2023 Apr; 654():34-39. PubMed ID: 36878037
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of CRISPR-Cas9 ribonucleoprotein complex assembly by anti-CRISPR AcrIIC2.
Thavalingam A; Cheng Z; Garcia B; Huang X; Shah M; Sun W; Wang M; Harrington L; Hwang S; Hidalgo-Reyes Y; Sontheimer EJ; Doudna J; Davidson AR; Moraes TF; Wang Y; Maxwell KL
Nat Commun; 2019 Jun; 10(1):2806. PubMed ID: 31243272
[TBL] [Abstract][Full Text] [Related]
10. Programmable RNA Cleavage and Recognition by a Natural CRISPR-Cas9 System from Neisseria meningitidis.
Rousseau BA; Hou Z; Gramelspacher MJ; Zhang Y
Mol Cell; 2018 Mar; 69(5):906-914.e4. PubMed ID: 29456189
[TBL] [Abstract][Full Text] [Related]
11. Gene drive inhibition by the anti-CRISPR proteins AcrIIA2 and AcrIIA4 in Saccharomyces cerevisiae.
Basgall EM; Goetting SC; Goeckel ME; Giersch RM; Roggenkamp E; Schrock MN; Halloran M; Finnigan GC
Microbiology (Reading); 2018 Apr; 164(4):464-474. PubMed ID: 29488867
[TBL] [Abstract][Full Text] [Related]
12. Structural Investigation of Self-Assembly and Target Binding of Anti-CRISPR AcrIIC2.
Kim Y; Lee SJ; Park C; Koo J; Bae E; Lee BJ; Suh JY
CRISPR J; 2021 Jun; 4(3):448-458. PubMed ID: 34042500
[TBL] [Abstract][Full Text] [Related]
13. Anti-CRISPR AcrIIC3 discriminates between Cas9 orthologs via targeting the variable surface of the HNH nuclease domain.
Kim Y; Lee SJ; Yoon HJ; Kim NK; Lee BJ; Suh JY
FEBS J; 2019 Dec; 286(23):4661-4674. PubMed ID: 31389128
[TBL] [Abstract][Full Text] [Related]
14. Naturally Occurring Off-Switches for CRISPR-Cas9.
Pawluk A; Amrani N; Zhang Y; Garcia B; Hidalgo-Reyes Y; Lee J; Edraki A; Shah M; Sontheimer EJ; Maxwell KL; Davidson AR
Cell; 2016 Dec; 167(7):1829-1838.e9. PubMed ID: 27984730
[TBL] [Abstract][Full Text] [Related]
15. Cas9 Allosteric Inhibition by the Anti-CRISPR Protein AcrIIA6.
Fuchsbauer O; Swuec P; Zimberger C; Amigues B; Levesque S; Agudelo D; Duringer A; Chaves-Sanjuan A; Spinelli S; Rousseau GM; Velimirovic M; Bolognesi M; Roussel A; Cambillau C; Moineau S; Doyon Y; Goulet A
Mol Cell; 2019 Dec; 76(6):922-937.e7. PubMed ID: 31604602
[TBL] [Abstract][Full Text] [Related]
16. Closely related type II-C Cas9 orthologs recognize diverse PAMs.
Wei J; Hou L; Liu J; Wang Z; Gao S; Qi T; Gao S; Sun S; Wang Y
Elife; 2022 Aug; 11():. PubMed ID: 35959889
[TBL] [Abstract][Full Text] [Related]
17. Francisella novicida CRISPR-Cas Systems Can Functionally Complement Each Other in DNA Defense while Providing Target Flexibility.
Ratner HK; Weiss DS
J Bacteriol; 2020 May; 202(12):. PubMed ID: 32284320
[TBL] [Abstract][Full Text] [Related]
18. AcrIIA28 is a metalloprotein that specifically inhibits targeted-DNA loading to SpyCas9 by binding to the REC3 domain.
Kim GE; Park HH
Nucleic Acids Res; 2024 Jun; 52(11):6459-6471. PubMed ID: 38726868
[TBL] [Abstract][Full Text] [Related]
19. The post-PAM interaction of RNA-guided spCas9 with DNA dictates its target binding and dissociation.
Zhang Q; Wen F; Zhang S; Jin J; Bi L; Lu Y; Li M; Xi XG; Huang X; Shen B; Sun B
Sci Adv; 2019 Nov; 5(11):eaaw9807. PubMed ID: 31763447
[TBL] [Abstract][Full Text] [Related]
20. AcrIIC4 inhibits type II-C Cas9 by preventing R-loop formation.
Sun W; Cheng Z; Wang J; Yang J; Li X; Wang J; Chen M; Yang X; Sheng G; Lou J; Wang Y
Proc Natl Acad Sci U S A; 2023 Aug; 120(31):e2303675120. PubMed ID: 37494395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
